Provided by Tiger Fintech (Singapore) Pte. Ltd.

Glaukos

92.99
+0.30000.32%
Post-market: 92.990.00000.00%19:10 EDT
Volume:653.29K
Turnover:61.03M
Market Cap:5.31B
PE:-40.99
High:95.00
Open:94.34
Low:92.92
Close:92.69
Loading ...

U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics

Reuters
·
01 May

Glaukos Corp (GKOS) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ...

GuruFocus.com
·
01 May

Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
01 May

GUIDANCE: (GKOS) Glaukos Reaffirms 2025 Net Sales Guidance $475 Million to $485 Million vs. FactSet Est $480.6 Million

MT Newswires Live
·
01 May

Stock Track | Glaukos Shares Plunge 6.63% After Hours Despite Beating Q1 Estimates

Stock Track
·
01 May

Glaukos Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Glaukos Reports Record Q1 2025 Net Sales Growth

TIPRANKS
·
01 May

Glaukos: Q1 Earnings Snapshot

Associated Press Finance
·
01 May

Glaukos Q1 Adj. EPS $(0.22) Beats $(0.35) Estimate, Sales $106.66M Beat $102.50M Estimate

Benzinga
·
01 May

BRIEF-Glaukos Q1 Sales USD 106.7 Million Vs. IBES Estimate USD 102.5 Million

Reuters
·
01 May

Wells Fargo Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
29 Apr

Here's Why You Should Add Veeva Stock to Your Portfolio Now

Zacks
·
25 Apr

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
23 Apr

Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Business Wire
·
23 Apr

Glaukos Announces the Release of its 2024 Sustainability Report

Business Wire
·
16 Apr

Glaukos price target lowered to $175 from $200 at Mizuho

TIPRANKS
·
16 Apr

Glaukos Is Maintained at Overweight by Piper Sandler

Dow Jones
·
15 Apr

U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group

Reuters
·
15 Apr

Glaukos price target lowered to $114 from $155 at BTIG

TIPRANKS
·
14 Apr

Glaukos Is Maintained at Buy by Truist Securities

Dow Jones
·
11 Apr